Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity
|Publication Date:||10 June 1998|
|ICS Code (Laboratory medicine):||11.100|
|ICS Code (Test conditions and procedures in general):||19.020|
|ICS Code (Protection against dangerous goods):||13.300|
1.1 This practice covers the introduction of foreign materials into the body that may have an impact on the immune system. One possible effect is that the immune system will be depressed or certain cell types may be affected. Immunotoxicity may be determined with blood and tissue samples from the animals used in the other biocompatibility test procedures such as implantation and blood contact test protocols. It is also possible to use these techniques with blood samples from human patients in a clinical trial. Any procedures with human subjects should follow the appropriate rules of the local institutional review board and the appropriate regulatory agencies. This document may serve as an annex to Practice F 748.
1.2 The material may affect the humoral immune response, the cell mediated response, or both.
1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.